Paediatric consumer health

Amway is the largest direct selling company in vitamins and dietary supplements globally. A pioneer of innovations, it distributes its Nutrilite premium assortments at comparatively high prices. The company faces rising pressure from other players…

Bayer AG continued to record growth during another challenging year in 2022, and despite the difficult operating environment created by the swift rise in global inflation and shortages to ingredients and raw materials, which has impacted growth…

After a successful demerger from GlaxoSmithKline Pc, Haleon Plc, formed in July 2022, continues to lead the consumer health industry, supported by its power brands. While North America is a key region, Asia Pacific, and the Middle East and Africa…

2022 presented challenges for Herbalife, as macroeconomic headwinds and inflationary pressures resulted in sales declines, pushing the company to withdraw its full-year guidance. However, the company is using the soft year to push its product…

Kenvue Inc retained its ranking as the second largest company within the consumer health industry after a successful demerger from Johnson & Johnson Inc in May 2023, supported by global power brands like Tylenol, Zyrtec, Imodium and Band-Aid. North…

As the population aged 0-12 continues to rise, paediatric consumer health is expected to register growth in 2023 in both volume and current value terms, with nappy (diaper) rash treatments leading the way, followed by paediatric vitamins and dietary…

Retail volume sales of paediatric cough, cold and allergy (hay fever) remedies saw positive growth for the second consecutive year in 2023. With the resumption of pre-pandemic lifestyles, including the return of students to school and infants to…

Compared with previous years, the rate of vaccination for children in Australia has declined in 2023, leaving the younger demographic more vulnerable to colds and flu. Given the nation endured an extended influenza season, sickness amongst children…

Paediatric consumer health has recorded a small sales decline in current value terms in 2023. Children are becoming more prone to getting sick now that the pandemic is over, with them not staying home as much anymore, going to school/daycare,…

Paediatric consumer health is on the upswing in Azerbaijan in 2023. In a post-pandemic era, parents s are once again comfortable letting their children roam free — from the playgrounds to the classrooms. More social interaction, however, increases…

While a growing number of adults are now working at home for at least one or two days during the week, most children are now back in nurseries and classrooms from morning until the afternoon, five days a week. As a result, children were not spared by…

In 2023, paediatric consumer health is expected to register a decline in current value sales. A contributing factor to the decline is that the birth rate is falling in Bolivia. That being said, birth rates are still high. Some products are expected…

Paediatric consumer health achieved strong current value growth in 2023, largely in response to rising unit prices and inflation impacting consumer health products in general. Consumer demand for children-specific consumer health products remains…

Paediatric consumer health is poised for solid growth in current value terms in Brazil in 2023, maintaining a rate of increase similar to that observed in 2022. While in 2022, in-person schooling exposed children to colds and flu, in 2023, another…

Parental preference for child-specific consumer health products is a progressively growing trend in Bulgaria, reflecting a strong desire for products tailored to the unique needs and sensitivities of children, in contrast to the more traditional…

Paediatric consumer health registered moderate current value growth in 2023, partly supported by continuing population growth. Essential consumer health products such as cough, cold and allergy remedies, as well as analgesics, were the most popular…

Paediatric cough/cold remedies is projected to deliver further strong retail volume and value (constant 2023 prices) growth in 2023. The growth in demand for these products is informed by the supply shortages of paediatric cold and flu remedies in…

Paediatric consumer health is experiencing similar value growth rates to the previous year in Chile, although this is not aligned with the increasing demand for this category during 2023. A notable challenge has emerged as there have been stock…

Notwithstanding the decline in the birth rate and the contraction in the infant population, which has had a direct negative impact on categories such as milk formula, it has not depressed demand for upgraded consumption in paediatric consumer health.…

Paediatric analgesics faced supply issues during 2022 and part of 2023, particularly with a scarcity of Dolex 7+ (a suspension that can be used for children aged 7 and above that has a different concentration from baby drops and adult acetaminophen).…